LEIDEN, The Netherlands, Oct. 23 -- Leiden University issued the following news: * * * Fourteen Leiden University researchers receive Vidi grant The Dutch Research Council (NWO) has awarded Vidi grants to 14 Leiden researchers. This grant of a maximum of 850,000 euros will enable them to start a new research group and develop their own line of research over the next five years. The Vidi grants are awarded to experienced researchers who have conducted several years of research since receiving  more

LONDON, England, Oct. 24 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on Oct. 23, 2025: * * * Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma * Significant unmet need for patients requires new and novel treatments/1 * DREAMM-7 showed a 51% reduction in the risk of death and tripled median progression-free survival in 3L+ indicated population versus a daratumumab-based triplet/2 * Blenrep is the only  more